Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

UMP HEALTHCARE HOLDINGS LIMITED

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 722)

INTERIM RESULTS ANNOUNCEMENT

FOR THE SIX MONTHS ENDED 31 DECEMBER 2021

The board of directors ("Board") of UMP Healthcare Holdings Limited (the "Company" or "UMP") is pleased to announce the interim results of the Company and its subsidiaries (collectively referred to as the "Group") for the six months ended 31 December 2021 together with the comparative figures for the corresponding period in 2020.

INTERIM RESULTS HIGHLIGHTS

Six months ended

31 December

2021

2020

Increase/

HK$'000

HK$'000

(decrease)

(Unaudited)

(Unaudited)

(Restated)

Continuing operations

Revenue

358,210

299,221

19.7%

Profit before tax

60,155

57,083

5.4%

Depreciation and amortisation

37,603

37,970

(1.0%)

Discontinued operation

1,197

Profit/(loss) for the period

(14,519)

108.2%

Continuing and discontinued operations

104,168

EBITDA(1)

83,358

25.0%

Profit for the period

50,371

32,574

54.6%

Revenue from continuing operations

Hong Kong & Macau Corporate

123,517

Healthcare Solution Services

121,615

1.6%

Hong Kong & Macau Clinical Healthcare Services

211,988

160,122

32.4%

Mainland China Clinical Healthcare Business

22,705

17,484

29.9%

358,210

299,221

19.7%

(1)

EBITDA represents earnings before interest (including interest expenses on lease liabilities), tax,

depreciation (including depreciation on right-of-use assets) and amortisation.

1

CONDENSED CONSOLIDATED STATEMENT OF PROFIT OR LOSS

Six months ended 31 December 2021

Six months ended 31 December

2021

2020

Notes

HK$'000

HK$'000

(Unaudited)

(Unaudited)

(Restated)

CONTINUING OPERATIONS

REVENUE

5

358,210

299,221

Other income and gains

5

4,278

3,832

Professional services expenses

(127,297)

(109,674)

Employee benefit expense

(83,890)

(51,972)

Property rental and related expenses

(4,637)

(3,913)

Cost of inventories consumed

(19,946)

(14,801)

Depreciation and amortisation

(37,603)

(37,970)

Other expenses, net

(29,245)

(27,018)

Finance cost

(1,834)

(1,804)

Share of profits of:

618

Joint ventures

-

Associates

1,501

1,182

PROFIT BEFORE TAX

6

60,155

57,083

Income tax expense

7

(10,981)

(9,990)

PROFIT FOR THE PERIOD FROM

CONTINUING OPERATIONS

49,174

47,093

Discontinued operation

1,197

Profit/(loss) for the period from discontinued operation

8

(14,519)

PROFIT FOR THE PERIOD

50,371

32,574

Attributable to:

Owners of the Company

44,661

From continuing operations

42,694

From discontinued operation

1,666

(11,615)

46,327

31,079

Non-controlling interests

4,044

1,495

50,371

32,574

EARNINGS/(LOSS) PER SHARE

ATTRIBUTABLE TO ORDINARY EQUITY

HOLDERS OF THE COMPANY

10

Basic and diluted

HK5.835 cents

- Continuing operations

HK5.640 cents

- Discontinued operation

HK0.218 cents

HK(1.535) cents

Total - included discontinued operation

HK6.053 cents

HK4.105 cents

2

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

Six months ended 31 December 2021

Six months ended

31 December

2021

2020

HK$'000

HK$'000

(Unaudited)

(Unaudited)

(Restated)

PROFIT FOR THE PERIOD

50,371

32,574

OTHER COMPREHENSIVE INCOME/(LOSS)

Other comprehensive income/(loss) that may be

reclassified to profit or loss in subsequent periods:

Exchange differences on translation of

foreign operations

707

2,494

Release of reserve upon disposal of

subsidiaries

(1,786)

1,279

Net other comprehensive income/(loss) that may be

reclassified to profit or loss in subsequent periods

(1,079)

3,773

Other comprehensive income/(loss) that will not be

reclassified to profit or loss in subsequent periods:

Changes in fair value of equity investments designated

at fair value through other comprehensive income

3,717

(2,411)

OTHER COMPREHENSIVE INCOME

FOR THE PERIOD, NET OF TAX

2,638

1,362

TOTAL COMPREHENSIVE INCOME

FOR THE PERIOD

53,009

33,936

Attributable to:

Owners of the Company

48,965

32,441

Non-controlling interests

4,044

1,495

53,009

33,936

3

CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION

31 December 2021

31 December

30 June

2021

2021

Notes

HK$'000

HK$'000

(Unaudited)

(Audited)

NON-CURRENT ASSETS

Property, plant and equipment

102,453

99,430

Right-of-use assets

87,765

73,666

Goodwill

164,768

164,768

Other intangible assets

60,767

61,681

Investments in joint ventures

8,589

7,970

Investments in associates

12,588

4,501

Financial assets at amortised cost

11

6,385

19,025

Investments at fair value through other

comprehensive income

12

26,967

23,603

Deferred tax assets

1,389

1,417

Deposits

19,175

20,544

Total non-current assets

490,846

476,605

CURRENT ASSETS

Inventories

10,479

9,198

Trade receivables

13

96,872

83,364

Prepayments, other receivables and

other assets

30,478

18,088

Financial assets at fair value through

profit or loss

31,807

27,115

Financial assets at amortised cost

11

26,613

14,046

Amounts due from associates

17,885

3,730

Amount due from a joint venture

2,151

451

Amounts due from related companies

1,894

1,220

Tax recoverable

69

551

Pledged deposits

2,393

1,893

Cash and cash equivalents

259,410

293,974

480,051

453,630

Assets of disposal groups classified as

held for sale

-

39,742

Total current assets

480,051

493,372

4

CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION

(CONTINUED) 31 December 2021

31 December

30 June

2021

2021

Notes

HK$'000

HK$'000

(Unaudited)

(Audited)

CURRENT LIABILITIES

44,243

Trade payables

14

62,185

Other payables and accruals

86,352

64,376

Amounts due to associates

117

-

Amounts due to related companies

2,269

5,618

Amount due to a joint venture

875

561

Lease liabilities

44,368

38,731

Tax payable

22,088

26,848

Liabilities associated with the disposal groups

200,312

198,319

-

classified as held for sale

24,441

Total current liabilities

200,312

222,760

NET CURRENT ASSETS

279,739

270,612

TOTAL ASSETS LESS CURRENT

LIABILITIES

770,585

747,217

NON-CURRENT LIABILITIES

46,767

Lease liabilities

39,296

Deferred tax liabilities

12,045

12,238

Provision

2,631

2,627

Total non-current liabilities

61,443

54,161

Net assets

709,142

693,056

EQUITY

Equity attributable to owners of the

Company

775

Issued capital

15

775

Reserves

668,834

638,723

669,609

639,498

Non-controlling interests

39,533

53,558

Total equity

709,142

693,056

5

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

UMP Healthcare Holdings Ltd. published this content on 24 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 March 2022 08:47:01 UTC.